# US 2013/0253135 A1 · Poly(amide) polymers for the delivery of oligonucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253135 A1
- Document ID: US20130253135A1
- Status: Published application
- Kind: A1
- Application number: 13/885,737
- Filed: 2011-11-16
- Published: 2013-09-26
- Earliest claimed: 2010-11-19
- Assignees: Alnylam Pharmaceuticals, Inc.
- Inventors: Stephanie E. Barrett; Marina Busuek; Steven L. Colletti; Robert M. Garbaccio; Erin N. Guidry; Robert A. Kowtoniuk; Jing Liao; Craig A. Parish; Rubina G. Parmar; Tao Pei; Kevin M. Schlosser; David M. Tellers; Sandra C. Tobias; Quang T. Truong; Jacob H. Waldman; Weimin Wang; J. Michael Williams
- Web page: https://patentgrep.com/patent/US20130253135A1

## CPC

- A61K 47/549: {Sugars, nucleosides, nucleotides or nucleic acids}
- C08G 69/10: Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)}
- C08G 73/028: {Polyamidoamines}
- C08L 79/02: Polyamines
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention provides poly(amide) polymers, polyconjugates, compositions and methods for the delivery of oligonucleotides for therapeutic purposes.

## Claims

### Claim 1

A polymer comprising Formula Z:
wherein:
x is 2 to 1000;
y is 2 to 1000;
R1 is a cationic component;
R2 is an aliphatic component or hydrogen;
Ra is independently selected from R1 and R2
Rb is independently selected from R1 and R2
Rc is independently selected from R1 and R2; and
Rd is independently selected from R1 and R2;
or stereoisomer thereof.

### Claim 2 (depends on 1)

A polymer according to claim 1 comprising Formula Z′:
wherein:
x is 2 to 1000;
y is 2 to 1000;
R is an initiator;
R′ is an end group;
R1 is a cationic component;
R2 is an aliphatic component or hydrogen;
Ra is independently selected from R1 and R2
Rb is independently selected from R1 and R2
Rc is independently selected from R1 and R2; and
Rd is independently selected from R1 and R2;
or stereoisomer thereof.

### Claim 3 (depends on 2)

A polymer according to claim 2 comprising Formula Z″:
wherein:
x is 2 to 250;
y is 2 to 250;
R is an initiator;
R′ is an end group; and
R2 is an aliphatic component or hydrogen;
or stereoisomer thereof.

### Claim 4 (depends on 1)

A polymer conjugate composition comprising the polymer of Formula Z of claim 1, a linker and an oligonucleotide.

### Claim 5 (depends on 4)

The polymer conjugate composition of claim 4 further comprising a masking agent.

### Claim 6 (depends on 4)

The polymer conjugate composion of claim 4 further comprising a targeting ligand.

### Claim 7 (depends on 4)

A polymer conjugate composition of claim 4 further comprising a masking agent and a targeting ligand.

### Claim 8 (depends on 1)

A polymer conjugate composition made by the 1) synthesis of an activated polymer comprising Formula Z of claim 1; 2) synthesis of an activated oligonucleotide; and 3) conjugation of the activated polymer with the activated oligonucleotide;
optionally including the addition of a masking agent and/or a targeting ligand.
